Clinical trials
Phase 1 Immune System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Active, not recruiting | 7 |
| Recruiting | 5 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | 5 |
| Kadmon, a Sanofi Company | 4 |
| AO GENERIUM | 3 |
| Memgen, LLC | 3 |
| CRISPR Therapeutics AG | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Kymab Limited | 2 |
| Nordic Nanovector | 2 |
| Stanford University | 2 |
| UCB Pharma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 57 |
| Autoimmune Diseases | 16 |
| Neoplasms | 10 |
| Immunoproliferative Disorders | 9 |
| Lymphoma | 8 |
| Lymphoproliferative Disorders | 7 |
| Neoplasms by Histologic Type | 7 |
| Connective Tissue Diseases | 6 |
| Lupus Erythematosus, Systemic | 6 |
| Cardiovascular Diseases | 5 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.